India: Licensing & Syndication

The viewpoint of being able to provide cheap drugs to a population which cannot afford it has started yet another debate in the pharma sector about how drug companies should price the life saving drugs in the developing world.

In an eagerly awaited decision, India's Controller of Patents has granted a licence to generics pharmaceutical manufacturer, Natco Pharma Ltd (Natco) to manufacture Bayer's patented anticancer drug 'Naxavar'.

In Scan Biotech India & Another v Scan Biotech India , Scan Biotech India & Another (Plaintiffs), a pharmaceutical product manufacturing concern sought permanent injunction against Scan Biotech India (Defendant) for their use of the trademark "BOLRAN" and the use of the trade name "SCAN BIOTEK INDIA".

Supreme Court recently examined interplay between copyright and design protection in a dispute concerning infringement of intellectual property rights...

Movies have become a part of our daily lives and we also closely relate ourselves with various characters that we see on screen. Those fictional movie characters have a great level of commercial appeal and popularity among the public.

Ambience is one of the main factors that are kept in mind while eating out, either when relaxing at a local coffee shop or dining in a restaurant or having a party or enjoying a special event.

Intellectual property laws allow its owners to exclude others from performing certain specified acts, at the same time it allows him to grant third parties special permission to perform any of those acts through licensing, while retaining ownership.

As millions tune into their love for cricket, we log into another IPL: the Indian policy landscape (IPL). This IPL looks more like a test match though, not a T20 — we are all in it for the long haul.

This IP newsletter covers categories of updates relating to Legal Updates, Industry Spotlight, Case Studies and Precedents, Practical Insights for IP Professionals...

Under Section 64 of the Patents Act, Act no. 39 of 1970, a patent may be revoked in India.

Holdings Corporation Vs Granules India Limited with respect to a patent dispute relating to Ruxolitinib (used for the treatment of myelofibrosis, a rare disorder of the bone marrow).

Patent revocation is the statutory process of cancelling a granted patent when it does not fulfill the required criteria of intellectual property law.